Cart
sales@molnova.com
Lofemizole
CAS No. 65571-68-8
Lofemizole( —— )
Catalog No. M28418 CAS No. 65571-68-8
Lofemizole is an antagonist of CYP1A2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 146 | Get Quote |
|
| 10MG | 219 | Get Quote |
|
| 25MG | 374 | Get Quote |
|
| 50MG | 555 | Get Quote |
|
| 100MG | 789 | Get Quote |
|
| 500MG | 1611 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLofemizole
-
NoteResearch use only, not for human use.
-
Brief DescriptionLofemizole is an antagonist of CYP1A2.
-
DescriptionLofemizole is an antagonist of CYP1A2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorSIRT2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65571-68-8
-
Formula Weight192.65
-
Molecular FormulaC10H9ClN2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1[nH]cnc1-c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shah AA, Ito A, Nakata A, Yoshida M. Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity. Biol Pharm Bull. 2016;39(10):1739-1742. PubMed PMID: 27725455.
molnova catalog
related products
-
CDD3506
CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
Tauroursodeoxycholic...
Tauroursodeoxycholic acid is the more hydrophilic form of ursodeoxycholic acid, which is the more abundant naturally produced bile acid in humans.
-
EN3356
EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.
